methylprednisolone hemisuccinate has been researched along with tobramycin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Hinshaw, LB; Ishida, K | 1 |
| Hayasaka, H; Hinshaw, LB; Ishida, K; Totsuka, M | 1 |
3 other study(ies) available for methylprednisolone hemisuccinate and tobramycin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Changes of plasma gastrointestinal glucagon concentrations following lethal infusions of E. coli.
Topics: Animals; Blood Glucose; Blood Pressure; Dogs; Escherichia coli Infections; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptides; Heart Rate; Methylprednisolone Hemisuccinate; Shock, Septic; Tobramycin | 1986 |
[Studies of plasma gastrointestinal glucagon after LD100 E. coli infusion].
Topics: Animals; Dogs; Drug Therapy, Combination; Escherichia coli Infections; Gastrointestinal Hormones; Glucagon-Like Peptides; Methylprednisolone Hemisuccinate; Prognosis; Sepsis; Tobramycin | 1985 |